If the article is wrong, Amarin should get them to correct it.
BBI, you know how many things are "out there" that Amarin needs to correct?
Damn, let's just start with all the articles and websites calling generic IPE "Generic Vascepa", or talking about how it helps prevent cardiovascular disease.
I think Amarin gave up even trying to fix this shit years ago.
Again, this is why I always go back to my contention that the new formulation is the future for Vascepa. If there's no generic, there can be no confusion.
Market Data 
Markets 
AI
